Teladoc’s long-time CEO is leaving

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

Teladoc Health’s CEO Ja­son Gore­vic is step­ping down, the com­pa­ny said on Fri­day, as the tele­health gi­ant’s stock dropped to an all-time low in eight years.

Teladoc’s stock dropped to around $14 per share when mar­kets opened Fri­day, the low­est price since 2016.

Gore­vic stepped in­to his role as CEO in 2009. He over­saw Teladoc’s IPO in 2015 and its ac­qui­si­tion of Livon­go in 2020. The com­pa­ny has strug­gled to make its ac­qui­si­tion of Livon­go prof­itable, re­port­ing a loss of $14 bil­lion on the deal in 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.